Physician

Naomi Rebecca Sullivan, M.D.

According to 2025 Medicare claims, Naomi Sullivan, M.D. (NPI: 1467436493) practices rheumatology in the Bellingham, WA market, with the plurality of this provider's patient population coming from Whatcom, WA. This provider's primary affiliated billing organization is BELLINGHAM ARTHRITIS & RHEUMATOLOGY (NPI: 1194086579; TIN: 455386318) and primary practice location at 98225-1781. Sullivan is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Sullivan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 492 traditional Medicare patients, billed 200,032 HCPCS/CPT codes, and received $2,381,433 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,946 prescription claims across 525 beneficiaries totaling $3,771,268 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 39 records totaling $911. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $430,451 to $2,381,433. Similarly, Part D prescription costs have moved sharply higher in recent years, from $542,335 to $3,771,268. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	238	28,898	$430,451
2016	281	30,304	$558,755
2017	304	35,051	$664,264
2018	323	38,200	$746,157
2019	335	54,331	$833,239
2020	319	61,174	$990,681
2021	307	81,808	$1,016,015
2022	307	104,462	$1,152,322
2023	322	123,981	$1,350,985
2024	492	200,032	$2,381,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	207	1,677	$542,335
2016	232	2,013	$507,597
2017	272	2,194	$716,836
2018	262	2,020	$860,950
2019	272	2,134	$1,126,172
2020	294	2,333	$1,480,737
2021	307	2,197	$2,050,481
2022	343	2,295	$2,541,799
2023	346	2,390	$3,079,223
2024	525	2,946	$3,771,268

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	80	370	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	402	680	$97
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	105	478	$53
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	399	682	$13
J7050	Infusion, normal saline solution, 250 cc	106	566	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	111	3,556	$1,438,191
Enbrel Sureclick	Etanercept	112	3,192	$856,096
Enbrel	Etanercept	61	1,904	$506,889
Orencia Clickject	Abatacept	49	1,372	$278,217
Xeljanz Xr	Tofacitinib Citrate	42	1,260	$248,707

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$911	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naomi Rebecca Sullivan, M.D.?

Tedicare shows public-source Medicare data for Naomi Rebecca Sullivan, M.D. (NPI 1467436493), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naomi Rebecca Sullivan, M.D. have ACO affiliation data?

Naomi Rebecca Sullivan, M.D. is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Naomi Rebecca Sullivan, M.D.?

Naomi Rebecca Sullivan, M.D. is linked to BELLINGHAM ARTHRITIS & RHEUMATOLOGY (billing NPI 1194086579) in the available physician profile data.

Does Naomi Rebecca Sullivan, M.D. have Open Payments data?

Naomi Rebecca Sullivan, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.